CON
Concentra Group Holdings Parent, Inc.
NYSE · USHealthcareMedical - Equipment & Services
$31.31-0.95%
Price as of Jul 20, 2026
CON financials
Concentra Group Holdings Parent, Inc. financial statements
Annual and quarterly income statement, balance sheet and cash-flow history. On small screens, start with four periods and expand the table when needed.
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $2.2B | $1.9B | $1.8B | $1.7B |
| Cost of revenue | $1.6B | $1.4B | $1.3B | $1.3B |
| Gross profit | $613.1M | $528.0M | $512.4M | $408.2M |
| Operating expenses | -$1.5B | $223.2M | $224.8M | $150.0M |
| Operating income | $2.1B | $304.8M | $287.6M | $258.2M |
| Net income | $172.8M | $166.5M | $179.9M | $166.7M |
| EBITDA | $408.9M | $368.3M | $360.2M | $330.2M |
| Basic EPS | $1.39 | $1.30 | $1.42 | $1.32 |
| Diluted EPS | $1.30 | $1.30 | $1.42 | $1.32 |
| Balance sheet | ||||
| Cash & equivalents | $79.9M | $183.3M | $31.4M | $37.7M |
| Total assets | $3.0B | $2.5B | $2.5B | $2.3B |
| Total liabilities | $2.6B | $2.2B | $1.3B | $1.3B |
| Stockholders’ equity | $393.3M | $275.7M | $1.2B | $973.3M |
| Total debt | $2.1B | $2.0B | $905.0M | $1.0B |
| Net debt | $2.0B | $1.8B | $873.6M | $1.0B |
| Cash flow | ||||
| Operating cash flow | $279.4M | $274.7M | $234.3M | $274.3M |
| Capital expenditure | -$82.3M | -$64.3M | -$69.3M | -$46.0M |
| Free cash flow | $197.1M | $210.3M | $165.0M | $228.4M |
| Dividends paid | -$32.1M | -$1.5B | -$6.1M | $0.00 |
| Share repurchases | -$22.4M | -$15.4M | -$5.3M | -$29.1M |